weak patent
A patent that should never have been granted and would likely be invalidated if challenged in court, yet still blocks competition because challenging it is costly.
As defined in Robin Feldman on Drug Patents, Generics, and Drug Wars
Where it comes up · 1
Most important claims · 2 of 2Search all claims for “weak patent” →
- When generics fight brand-name patents through Paragraph IV certification challenges, they win about three-quarters of the time, indicating how many of the challenged patents are weak—yet litigating still costs money and time during which the brand retains its monopoly.Robin Feldman on Drug Patents, Generics, and Drug Wars
- A weak patent is not one easily worked around but one that ought never to have been granted and should be invalidated; of roughly 2 million patents outstanding, many would not survive a court challenge, yet they sit on the books blocking competition because challenging them is costly and uncertain.Robin Feldman on Drug Patents, Generics, and Drug Wars